Create high-quality medication to benefit
patients worldwide.
Cancer
In 2024, there were approximately 20.6 million new cases of cancer globally, with about 9.8 million deaths. Cancer, characterized by high mortality rates, poor prognosis, and expensive treatment costs, is currently the greatest medical and health issue facing humanity. The company is currently engaged in the research and development of new drugs for the treatment of prostate cancer, breast cancer, hematological tumors, and other diseases.
Metabolic Disease
Metabolism refers to the series of chemical transformations that occur in biological cells. Through metabolic activities, energy that is required to support important physiological activities is obtained, and newly produced substances are absorbed or excreted. Metabolic diseases arise when these physiological mechanisms are in disorder. Metabolic disorders can be either inherited or acquired. Hinova is currently working on new drug development for the treatment of hyperuricemia/gout and non-alcoholic steatohepatitis (NASH).